Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M)

Journal of Nephrology

Volumn 16, Issue 3, 2003, Pages 438-442

  Lobato, Luísa ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

Amyloidosis; End stage renal disease; Familial; Hereditary; Kidney; Neuropathy; Proteinuria; Transthyretin

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; IRON; METHIONINE; MUTANT PROTEIN; PREALBUMIN; RECOMBINANT ERYTHROPOIETIN;

AMINO ACID SUBSTITUTION; ANEMIA; AUTONOMIC NEUROPATHY; CLINICAL FEATURE; CONFERENCE PAPER; DIALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG MEGADOSE; FAMILIAL AMYLOID POLYNEUROPATHY; FAMILIAL INCIDENCE; GENETIC COUNSELING; GENETIC IDENTIFICATION; GLOMERULOPATHY; HEALTH SURVEY; HUMAN; IMMUNOADSORPTION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY MEDULLA; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; LIVER TRANSPLANTATION; MICROALBUMINURIA; MOTOR NEUROPATHY; NEUROLOGIC DISEASE; ONSET AGE; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PORTUGAL; PROSPECTIVE STUDY; PROTEINURIA; SENSORY NEUROPATHY; SURVIVAL; VASCULAR DISEASE;

AMYLOIDOSIS; HUMANS; JAPAN; MUTATION; PORTUGAL; PREALBUMIN; PREVALENCE; SWEDEN;

EID: 0038127264     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Saraiva MJ, Costa PP, Goodman DS. Genetic expression of a transthyretin mutation in typical and late-onset families. Neurology 1986; 36: 1413-7.
2. Benson MD. Polyneuropathie amylöide familiale. In Grateau G, Benson MD, Delpech M Ed. Les Amyloses. Paris: Médecine-Sciences Flammarion 2000; 445-56.
3. Connors LH, Richardson AM, Theberge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000; 7: 54-69.
4. Saraiva MJ, Birken S, Costa PP, Goodman DS. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (pre-albumin). J Clin Invest 1983; 74: 104-19.
5. Blake CC, Geisow MJ, Oatley SJ. Structure of prealbumin: Secondary, tertiary and quarternary interactions determined by Fourier refinement at 1.8 Å. J Mol Biol 1978; 121: 339-56.
6. Costa RH, Lai E, Darnell JE. Transcriptional control of the mouse prealbumin (transthyretin) gene: Both promotor sequence and a distinct enhancer are cell specific. Mol Cell Biol 1986; 6: 4697-708.
7. Kanda Y, Goodman DS, Canfield RE, Morgan FJ. The amino acid sequence of human plasma prealbumin. J Biol Chem 1974; 249: 6796-805.
8. Inouye H, Domingues FS, Damas AM, Saraiva MJ, Lundgren E, Sandgren O, Kurschner DA. Amyloid 1998; 5: 163-74.
9. Cavallaro T, Martone RL, Dwork AJ. The retinal epithelium is the unique site of transthyretin synthesis in the rat eye. Invest Ophthalmol Vis Sci 1990; 31: 497-501.
10. Herbert J, Wilcox JN, Pham KT, Fremeau RT Jr, Zeviani M, Dwork A, Soprano DR, Makover A, Goodman DS, Zimmerman EA. Transthyretin: A choroids plexus-specific transport protein in human brain. Neurology 1986; 36: 900-11.
11. Saraiva MJ, Costa PP, Goodman DS. Studies on plasma transthyretin (prealbumin) in familial amyloid polyneuropathy, Portuguese type. J Lab Clin Med 1983; 102: 590-603.
12. Sasaki H, Yoshioka N, Takagi Y, Sakaki Y. Structure of the chromosomal gene for human serum prealbumin. Gene 1985; 37: 191-7.
13. Saraiva MJ. Transthyretin mutations in health and disease. Hum Mutat 1995; 5: 191-6.
14. Alves IL, Jacobson DR, Torres MF, Coelho T, Holmgren G, Saraiva MJ. Compound heterozygoty in patients with TTR-related amyloidosis. Neuron Disorders 1996; 8 (suppl 51): S19.
15. Westermark P, Sletten K, Johansson B, Cornwell GG. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A 1990; 87: 2843-5.
16. Andrade C. A peculiar form of peripheral neuropathy: Familial atypical generalized amyloidosis with specifical involvement of the peripheral nerves. Brain 1952; 75: 408-27.
17. Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP) - Type I in Póvoa do Varzim and Vila do Conde (North of Portugal). Am J Med Genet 1995; 60: 512-21.
18. Alves IL, Atland K, Almeida MR, Winter P, Saraiva MJ. Screening and biochemical characterization of transthyretin variants in the Portuguese population. Hum Mutat 1997; 9: 226-33.
19. Holmgren G, Holmberg E, Lindstrom A, Lindstrom E, Nordenson I, Sandgren O, Steen L, Svensson B, Lundgren E, Von Gabain A. Diagnosis of familial amyloidotic polyneuropathy in Sweden by RFLP analysis. Clin Genet 1988; 33: 176-80.
20. Sousa A. A variabilidade fenotípica da polineuropatia amiloidótica familiar: Um estudo de genética quantitativa em Portugal e na Suécia. PhD thesis, Universidade do Porto; 1994.
21. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familail Amyloidotic polyneuropathy in Sweden: Geographical distribution, age of onset and prevalence. Hum Hered 1993; 43: 293-9.
22. Araki S, Mawatari S, Ohta M, Nakajima A, Kuroiwa Y. Polyneuritic amyloidosis in a Japanese family. Arch Neurol 1968; 18: 593-602.
23. Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: Long term follow-up. Br J Ophthalmol 1997; 81: 295-98.
24. Beirão I, Lobato L, Ramallo M, Silva M, Santos MJ, Guimarães S. Characterization and management of anemia in familial amyloid polyneuropathy TTR V30M (FAP-I). In Miklós Bély, Ágnes Apathy Eds. Amyloid Symposium on Amyloidosis, Budapest: MBA Harvard 2001; 301-3.
25. Ramallo M, Beirão I, Lobato L, Silva M, Guimarães M. Intercurrent disease in familial amyloid polyneuropathy TTR V30M (FAP-I). In Miklós Bély, Ágnes Apathy Eds. Amyloid and Amyloidosis. The Proceedings of the International Symposium on Amyloidosis, Budapest: MBA Harvard 2001; 313.
26. Lobato L, Beirão B, Guimarães SM, Droz D, Guimarães S, Grünfeld JP, Noël LH. Familial amyloid polyneuropathy type I (Portuguese): Distribution and characterization of renal amyloid deposits. Am J Kidney Dis 1998; 6: 940-6.
27. Lobato L, Beirão I, Silva M, Sequeiros J, Sousa A. How to counsel carriers of transthyretin Val30Met mutation and end-stage renal disease in the family? In Miklós Bély, Ágnes Apathy Eds. Amyloid and Amyloidosis. The Proceedings of the International Symposium on Amyloidosis, Budapest: MBA Harvard 2001; 310-2.
28. Lobato L, Beirão I, Silva M, Bravo F, Silvestre F, Guimarães S, Alda Sousa, Noël LH, Sequeiros J. Familial Amyloidosis ATTR: Microalbuminuria as a predictor of symptomatic disease and clinical nephropathy. Nephrol Dial Transplant 2003; 18: 532-8.
29. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN, Pepys MB. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341: 1113-6.
30. Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Planté V, Ducot B, Ichai P, Lacroix C, Stephane M, Bismuth H, Said G. The course and prognostic factors of famial amyloid polyneuropathy after liver transplantation. Brain 2000; 123: 1495-504.
31. Almeida MR, Alves IL, Sakaki Y, Costa PP, Saraiva MJ. Prenatal diagnosis of familial amyloidotic polyneuropathy: Evidence for an early expression of the associated transthyretin methionine 30. Hum Genet 1990; 85: 623-6.
32. Calvalho F, Sousa M, Fernandes S, Silva J, Saraiva MJ, Barros A. Preimplantation diagnosis for familial amyloidotic polyneuropathy (FAP). Prenatal Diagn 2001; 21: 1093-9.